Local websites
Businesses
Other websites
General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

More information

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

More information

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

More information

pane 4 content

Media contacts

Find contact information for media inquiries. »

Novartis newsrooms

Explore links to the Newsrooms of Novartis divisions and businesses including Animal Health, CIBA Vision, Oncology, Sandoz, Vaccines & Diagnostics, and Research functions. »

Corporate Fact Sheet

Find comprehensive information about Novartis in one convenient electronic press kit. »

Media library

Visit our media library

Media releases

01-Feb-2012
FDA approves Novartis drug Glivec® label recommending extending treatment to three years for certain GIST patients after surgery

30-Jan-2012
Novartis extends commitment to help achieve final elimination of leprosy

25-Jan-2012
Novartis delivers strong underlying financial performance in 2011, expects 2012 sales to be in line with 2011

Featured news

Get the latest on Novartis through recent headlines, feature stories and videos. »

Rasilez/Tekturna information center

We'd like to share some information about the Rasilez/Tekturna ALTITUDE study. Download the PDFs for frequently asked questions. »

Glivec information center

Receive updates on the Glivec patent case in India »

Corporate publications

Download or order key corporate publications. »

Stay up-to-date

Stay up-to-date on the latest news and information from Novartis. »

Top links
Top downloads
World leprosy day

World Leprosy Day: Novartis continues fight to end leprosy ›

Annual report 2011

Annual report 2011 >